论文部分内容阅读
(2017-01-19)[2017-01-26]http://www.sda.gov.cn/WS01/CL0844/168687.html各省、自治区、直辖市食品药品监督管理局,新疆生产建设兵团食品药品监督管理局:近日,总局接到云南省局《关于云南南诏药业有限公司生产骨肽注射液有关情况的报告》(云食药监稽业[2017]2号),反映在贵州省沿河土家族自治县发现标示为云南南诏药业有限公司生产的骨肽注射液(批号:150920E1)引
(2017-01-19) [2017-01-26] http://www.sda.gov.cn/WS01/CL0844/168687.html Provinces, autonomous regions and municipalities directly under the State Food and Drug Administration, Xinjiang Production and Construction Corps Food and Drugs Supervision and Administration Bureau: Recently, the General Administration of Yunnan Province received a report titled "Report on the Production of Bone Peptide Injection by Nanzhao Pharmaceutical Co., Ltd. (Yunfu Jiao Ji Ye [2017] No. 2), which is reflected in the report of Yunnan Provincial Bureau He Tu Tu Autonomous County found that Yunnan Nanzhao Pharmaceutical Co., Ltd. produced bone peptide injection (batch number: 150920E1) cited